Vestibular migraine is a common cause of episodic vertigo and dizziness and affects up to 3% of all people. Characteristic symptoms include frequent episodes of vertigo (at least 5 attacks required) of varying duration (5 minutes to 72 hours) and at least moderate intensity, accompanied by other symptoms typical of migraine....
Audiologists and vestibular specialists should review updated diagnostic criteria and emerging pharmacological strategies outlined in this review, particularly for patients presenting with episodic vertigo of unclear origin.
Vestibular migraine is one of the most common yet underdiagnosed causes of episodic vertigo, and emerging treatment strategies may improve referral and co-management pathways between audiology and neurology.
- 01Vestibular migraine affects up to 3% of the population and is a leading cause of episodic vertigo (sudden dizziness episodes).
- 02The article reviews recent advances in diagnosis and treatment strategies.
- 03Future treatment options are explored, suggesting an evolving therapeutic landscape.
- 04Published in Laryngorhinootologie, a peer-reviewed ENT/audiology journal.
- 05Relevant to audiologists involved in vestibular assessment and patient triage.
Vestibular migraine affects up to 3% of the population.
studysupported- PMID
- 42335970
- DOI
- 10.1055/a-2881-5957.
- Journal
- Laryngorhinootologie
- Publication type
- review
- Evidence level
- 5
- Population
- Not specified; review covers literature on vestibular migraine patients
- Intervention
- Review of diagnostic approaches and treatment strategies for vestibular migraine
Primary outcomes
Diagnostic criteria and accuracy for vestibular migraine; Efficacy of current and emerging treatment strategies